March 14, 2025

In Novosibirsk (Russia), the construction of a plant for the production of pharmaceutical equipment has been planned.

Pharma

A large-scale production facility for manufacturing equipment for the pharmaceutical industry is planned to be established in the "Novosib" park. The company "Koordinata" has already begun implementing the project. Currently, the investor is awaiting an easing of credit conditions and is refining technologies for subsequent scaling, reports the Infopro54 portal, citing Alexander Tarasov, deputy general director of LLC "Novaya Lizingovaya Kompaniya" and a member of the Novosibirsk City Council.

Production is expected to be launched in the "Novosib" industrial park, located on the left bank of the metropolis. "Koordinata" has been a resident of the park since 2020. The company's commercial director, Mikhail Vorobyev, noted that over the past four years, the production area has increased from 100 to 800 square meters. According to him, such growth is due to the departure of foreign manufacturers from the Russian market.

"We used to develop production lines for insulin and various liquid pharmaceutical forms, but after the market opened up, we gained the opportunity to enter new niches. For example, we are now actively focusing on manufacturing equipment for producing tablet forms of medications. Moreover, we're talking about creating our own developments, not just engineering. Our company has its own design bureau that handles these tasks," emphasized Vorobyev.

He added that the company plans to double its production volume. Building a new plant is also in the future plans. However, the implementation of this project depends on financial considerations. Additionally, requirements for pharmaceutical equipment are strictly regulated, so even amid import substitution, companies must maintain high-quality standards.

"The economy is on the handbrake, and developing using internal resources alone isn’t happening as quickly as we’d like," he added.

Currently, 114 enterprises operate within the "Novosib" park, 39 of which are manufacturing companies. The turnover of the industrial park’s residents exceeds 9.8 billion rubles. According to data from "Kontur.Focus," LLC "Koordinata" was established in 2017. Dmitry Zhalybin is listed as its director and founder. The company's revenue amounts to 72.7 million rubles (+298%), with a net profit of 2.3 million rubles.

 

Source: GxPnews

WerExpro
Latest posts by email:
To subscribe to the newsletter, first Come in Either Register

Other news

Pharma

On behalf of the entire WEREVA.NET website team, we warmly congratulate you on the 80th Anniversary of the Great Victory!

09.05.2025
Pharma

Drug labeling system today is a full-fledged part of the pharmaceutical market reality. JSC "Promis" highlighted the role of domestic manufacturers in supplying the market with equipment and software, as well as presented its own line of developments.

27.05.2025
Pharma

From June 17 to 19, the exhibitions Rosmould and Rosplast will take place at the Crocus Expo IEC in Moscow.

21.05.2025
Pharma

The National Commission of the People's Republic of China has published 50 new national food product standards and 9 amendments to existing regulations.

20.05.2025
Pharma

State Duma Deputy Yaroslav Nilov has submitted a draft law proposing amendments to the Federal Law No. 61-FZ of April 12, 2010, "On Circulation of Medicinal Products."

12.05.2025
Pharma

Saint Petersburg supports the development of pharmaceutical and other high-tech industries by providing engineering-ready sites and ensuring a favorable investment climate.

06.05.2025
Pharma

"Sibur" has developed transparent polypropylene for safe syringes, reports "Medical Russia."

30.04.2025
Pharma

Half a billion rubles will be invested in the development of the "Pharmasynthesis-Tyumen" plant, as reported by Vikram Puniya, President of the Pharmasynthesis Group.

25.04.2025
Pharma

In the Volgograd region, they have revisited the idea of creating a chemical-pharmaceutical cluster. Representatives of the Scientific Center for Innovative Medicines are conducting relevant negotiations with potential partners.

14.04.2025
Pharma

Deputy Minister of Health of the Russian Federation Evgeny Kamkin and Health Minister of the Philippines Theodore Erbo agreed on expanding cooperation in the export of pharmaceuticals to the Philippines.

10.04.2025
Pharma

Tomsk-based company "Artlife," which is the largest producer of gelatin capsules in Russia, plans to enter new sales markets.

09.04.2025
Pharma

The cosmetics manufacturer WNT Production Group has launched the production of oral care products for its own brands, including toothpastes, sprays, mouthwashes, and foams, as well as products for professional dental procedures.

08.04.2025